Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...
Discover the best sectors for growth stocks in the next decade. Explore which sectors may present an opportunity to bolster ...
Hims & Hers Health (HIMS) stock hit a new all-time high on Thursday as retail investors have taken interest in the telehealth ...
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don’t just<a class="excerpt-read-more" href=" More ...
This innovative program addresses global health initiatives and medical training in Peru with Partners in Health, known ...
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country's biopharma sector ...
18h
MarketBeat on MSNWill Eli Lilly Stock Keep Climbing? Q2 Trial Results Are CrucialEli Lilly and Company (NYSE: LLY) is one of two pharmaceutical stocks behind the weight loss drug craze that has impacted the ...
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on UnitedHealth (UNH – Research Report) and Eli ...
Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results